American Portfolios Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$8.07K Hold
150
﹤0.01% 2620
2022
Q2
$6.05K Sell
150
-300
-67% -$14.9K ﹤0.01% 2757
2022
Q1
$29.8K Buy
450
+300
+200% +$20.5K ﹤0.01% 2149
2021
Q4
$15K Hold
150
﹤0.01% 2442
2021
Q3
$18.8K Buy
150
+25
+20% +$2.97K ﹤0.01% 2318
2021
Q2
$15.5K Hold
125
﹤0.01% 2322
2021
Q1
$19.1K Sell
125
-50
-29% -$7.56K ﹤0.01% 2098
2020
Q4
$22.6K Buy
175
+41
+31% +$4.72K ﹤0.01% 1761
2020
Q3
$15K Buy
134
+9
+7% +$823 ﹤0.01% 1825
2020
Q2
$10.1K Hold
125
﹤0.01% 1915
2020
Q1
$8.7K Hold
125
﹤0.01% 1869
2019
Q4
$9.77K Sell
125
-150
-55% -$10.8K ﹤0.01% 2005
2019
Q3
$17.6K Sell
275
-25
-8% -$2.2K ﹤0.01% 1722
2019
Q2
$25.9K Sell
300
-125
-29% -$9.55K ﹤0.01% 1567
2019
Q1
$32.6K Sell
425
-275
-39% -$15.2K ﹤0.01% 1380
2018
Q4
$26.3K Buy
+700
New +$25.8K ﹤0.01% 1273

Other funds holding GH

American Portfolios Advisors's GH Position: Q3 2022 in Review

American Portfolios Advisors held its Guardant Health (GH) position steady in Q3 2022 at 150 shares worth $8.07K. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

American Portfolios Advisors first reported a position in GH in Q4 2018 and has held it in 16 quarters since. The position peaked at $32.6K in Q1 2019. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

  • American Portfolios Advisors held 150 shares of Guardant Health worth $8.07K as of Q3 2022.
  • American Portfolios Advisors left its Guardant Health share count unchanged in Q3 2022.
  • Guardant Health made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2620 holding.
  • American Portfolios Advisors first reported a position in Guardant Health in Q4 2018 and has held it in 16 quarters since.
  • American Portfolios Advisors's Guardant Health position peaked at $32.6K in Q1 2019.
  • 328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.